With the analysis among 168 patents, we discovered top 32 key players by total patent application. Geron Corp., Aop Orphan Pharmaceuticals GmbH, Kartos Therapeutics, Inc. are dominant in this area. They take 53.57% of the total patent filing.
California, United States
Patent: 42
California, United States
Patent: 23
California, United States
Patent: 16
Lombardia, Italy
Patent: 11
Massachusetts, United States
Patent: 11
California, United States
Patent: 3
Taiwan Province, China
Patent: 3
With the analysis among 24 patents, we discovered top 1 start-ups by total patent application.
California, United States
Patent: 23
With the analysis among related 49 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Kartos Therapeutics, Inc., Geron Corp., Acceleron Pharma, Inc. take 71.43% of patent filing during this period.
California, United States
Patent: 23
California, United States
Patent: 8
Massachusetts, United States
Patent: 4
Massachusetts, United States
Patent: 1
Massachusetts, United States
Patent: 1
Shandong Sheng, China
Patent: 1
Massachusetts, United States
Patent: 1
undefined undefined
Patent: 1
With the analysis among related 49 patents in last 5 years, we discover 6 new entrants. Kartos Therapeutics, Inc., Ono Pharmaceutical Co., Ltd., The Children's Medical Center Corp. are the most active new entrants in this area.
California, United States
Patent: 23
Massachusetts, United States
Patent: 1
Shandong Sheng, China
Patent: 1
Massachusetts, United States
Patent: 1
undefined undefined
Patent: 1
With the analysis among 19 patents, we discovered top 7 universities and scientific research institutions by total patent application. Institut Gustave Roussy EURL, Massachusetts Institute of Technology, President & Fellows of Harvard College are dominant in this area. They take 52.63% of the total patent filing.
Institut Gustave Roussy EURL
Massachusetts, United States
Patent: 2
Massachusetts, United States
Patent: 2
Pennsylvania, United States
Patent: 1
Iwate-ken, Japan
Patent: 1